Home SWIB Holdings

SWIB Holdings

Procella Therapeutics and Smartwise Enter Collaboration With AstraZeneca to Develop Novel Cardiovascular and Catheter-based Therapies

5/7/18: The Extroducer catheter was developed at the Karolinska Institutet for potential uses in cancer treatment and tissue repair in various organs and was subsequently coated with Bactiguard technology. Both Procella and Smartwise are SWIB Holding (SWIBCo) subsidiaries.